AI assistant
Smith & Nephew PLC — Director's Dealing 2020
Feb 7, 2020
4588_dirs_2020-02-07_2b5e188d-7eda-4599-9db0-5f5cf02a910e.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 3885C
Smith & Nephew Plc
07 February 2020
SMITH & NEPHEW PLC
7 February 2020
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM.
Smith & Nephew plc (the "Company") announces that it has been informed of changes to the share interests of PDMRs in the Company, detailed below, following completion of the related performance periods.
Smith & Nephew Global Share Plan 2010 (Performance Share Awards):
| Name of PDMR | Number of ordinary shares under award granted on 07/03/2017 (shown at maximum) | Number of ordinary shares lapsed under award (shown at maximum) |
| Graham Baker | 79,166 | 40,375 |
| Bradley Cannon | 44,942 | 22,921 |
| Phil Cowdy | 16,022 | 8,172 |
| Elga Lohler | 25,612 | 13,063 |
| Catheryn O'Rourke | 15,138 | 7,721 |
| Vasant Padmanabhan | 32,996 | 16,828 |
| Susan Swabey | 11,402 | 5,816 |
Notes:
(i) Following completion of the performance measurement period, 98% of the target awards made on 7 March 2017 vested.
(ii) At maximum, 51% of awards have lapsed on 6 February 2020 and the remaining 49% of awards will vest and subject to continued employment, will be settled on 9 March 2020 being the first business date after the third anniversary of the awards.
This announcement is made in accordance with the requirements of Article 19 (3) of the Market Abuse Regulation.
Vickie Reuben
Deputy Company Secretary
Smith & Nephew plc
Tel: 01923 477216
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHFLFIEFTIDIII